Genescà A, Caballín M R, Miró R, Benet J, Bonfill X, Egozcue J
Departament de Biologia Cel.lular i Fisiologia, Universitat Autònoma de Barcelona, Spain.
Cancer Genet Cytogenet. 1990 Jun;46(2):251-60. doi: 10.1016/0165-4608(90)90110-v.
The long-term cytogenetic effect of radio- or chemotherapy or both on male germ cells was evaluated by study of the chromosomal abnormalities in spermatozoa of four men treated for cancer 5-18 years earlier. The cytogenetic analysis of 422 sperm metaphases showed no differences in the aneuploidy rate. The incidence of structural chromosome aberrations was 14.0%, however, which is much higher than in controls. Thus, the high incidence of structurally aberrant spermatozoa observed in our long-term study indicates that antitumoral treatments affect stem-cell spermatogonia and that aberrant cells can survive germinal selection and produce abnormal spermatozoa.